Six reports have been confirmed as linked to the vaccine, while three more instances are considered probable.
The confirmed cases are two women in NSW aged 60 and 82, a 72-year-old man from WA, a 51-year-old WA woman, a 73-year-old Victorian woman and a 63-year-old Queensland man.
The three probable cases are in an 85-year-old NSW woman, a 62-year-old Victorian man and a 76-year-old Victorian woman.
WA Health said they are working with the TGA to investigate the cases in that state.
“One is a woman, aged in her early 50s, who is currently in a stable condition at a Perth metropolitan hospital,” WA Health said in a statement.
“The second is a male in his 70s, also from the Perth metropolitan area, who is recovering at home.”
Nine people remain in hospital from blood clots connected to the vaccine.
Seventeen have been discharged from hospital, and four have left but need outpatient care.
The vaccine is recommended for people aged over 50 in Australia, with blood clots very rare.
About 50 Australians every day develop blood clots.
Australians who have a family history of blood clots or incidences of deep vein thrombosis do not have a higher chance of vaccine-induced thrombotic thrombocytopenia – or TTS – occurring after receiving an AstraZeneca dose.
The other patients recovered.
